iRadimed Corporation (NASDAQ:IRMD) has scheduled a conference call for 30th October 2020 at 11:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.iradimed.com
Earnings Expectation
iRadimed Corporation is reporting third quarter financial results on Friday 30th October 2020, before market open.
According to analysts surveyed by Thomson Reuters, IRMD is expected to report 3Q20 income of $ 0.10 per share from revenue of $ 8.21 million.
For the full year, analysts anticipate top line of $ 33.24 million, while looking forward to income of $ 0.48 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 46.30 million ~ $ 47.10 million, where as bottomline are predicted in a range of $ 0.84 ~ $ 0.92 per share
Click Here For More Historical Outlooks Of iRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
